Table 2.
Characteristics of articles included under the framework article type* (n = 27) by country focus and vaccine, systematic review of national decision-making 2010–2020.
| Frameworks | Country focus and income level | Vaccine | Category | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaccine characteristics | The importance of the health problem | Financial/economic issues | Considerations of the alternative interventions | Decision making process | Impact of vaccination | Programmatic considerations | Acceptability | Accessibility, equity, and ethics | |||
| Ceyhan, 2010 [8] | Turkey, UMIC | None specifically | X | X | X | X | X | X | |||
| Houweling et al., 2010 [9] | The Netherlands, HIC | HBV | X | X | X | X | X | X | X | ||
| John, 2010 [10] | India, LMIC Gavi | None specifically | X | X | X | X | X | ||||
| La Torre et al., 2010 [11] | Italy, HIC | HPV | X | X | X | X | X | X | X | X | |
| Levine et al., 2010 [12] | LIC and LMIC, all Gavi supported countries | Hib | X | X | X | X | X | X | |||
| Levine et al., 2010 [13] | Global, Gavi and non-Gavi supported countries | Hib | X | X | X | X | X | X | X | ||
| Ahmed et al., 2011 [14] | USA, HIC | None specifically | X | X | X | X | X | X | X | X | |
| Blecher et al., 2012 [15] | South Africa, UMIC | PCV, Rotavirus | X | X | X | X | X | X | X | ||
| Brooks et al., 2012 [16] | Global, Gavi and non-Gavi supported countries | Malaria | X | X | X | X | X | X | X | ||
| Cho, 2012 [17] | South Korea, HIC | None specifically | X | X | X | X | X | ||||
| Georgousakis et al., 2012 [18] | Australia, HIC | HPV | X | X | X | X | X | X | X | X | |
| Ngcobo et al., 2012 [19] | South Africa, UMIC | None specifically | X | X | X | X | X | X | |||
| Schoub, 2012 [20] | South Africa, UMIC | IPV | X | X | X | X | X | X | X | ||
| Ahout et al., 2014 [21] | The Netherlands, HIC | Influenza | X | X | X | X | X | X | |||
| Betancourt-Cravioto et al., 2014 [22] | Mexico, UMIC | Dengue | X | X | X | X | X | X | |||
| Domingues et al., 2014 [23] | Brazil, UMIC | IPV | X | X | X | X | X | X | X | X | |
| Falleiros-Arlant et al., 2014 [24] | Global, Gavi and non-Gavi supported countries | IPV | X | X | X | ||||||
| Rao et al., 2014 [25] | India, LMIC Gavi | Rotavirus | X | X | X | X | X | X | |||
| Stecher et al., 2014 [26] | Argentina, UMIC | None specifically | X | X | X | X | X | X | X | X | |
| Phelps et al., 2016 [27] | Global, Gavi and non-Gavi supported countries | None specifically | X | X | X | X | X | X | X | X | |
| Seib et al., 2017 [28] | USA, UK, Canada, Australia | None specifically | X | X | X | X | X | X | X | X | X |
| Dawa et al., 2019 [29] | Kenya | Seasonal influenza | X | X | X | X | X | X | X | X | X |
| De Wals et al., 2019 [30] | Canada | None specifically | X | X | X | X | X | X | X | X | |
| Floret 2019 [31] | France | None specifically | X | X | X | X | X | X | X | X | |
| Rattanavipapong et al., 2020 [32] | Thailand | Rotavirus | X | X | X | X | X | X | X | ||
| Sekhar et al., 2020 [33] | India | Cholera | X | X | X | X | X | X | X | X | |
| Taychakhoonavudh et al., 2020 [34] | Association of Southeast Asian Nations (ASEAN) countries | None specifically | X | X | X | X | X | X | |||
| Total (n) | 27 | 26 | 26 | 25 | 24 | 20 | 15 | 11 | 13 | ||
*
Article type 1, Frameworks.
Definitions: LIC, Low Income Country; LMIC, Lower-Middle Income Country; UMIC, Upper-Middle Income Country; HIC, High Income Country; Gavi, Gavi, the Vaccine Alliance; HBV, Hepatitis B vaccine; HPV, Human Papillomavirus vaccine; Hib, Haemophilus influenzae type b vaccine; PCV, pneumococcal conjugate vaccine; IPV, Inactivated Polio vaccine.